147 related articles for article (PubMed ID: 10369954)
1. Economic evaluation studies in nuclear medicine: the need for standardization.
Dietlein M; Knapp WH; Lauterbach KW; Schicha H
Eur J Nucl Med; 1999 Jun; 26(6):663-80. PubMed ID: 10369954
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules.
Gould MK; Sanders GD; Barnett PG; Rydzak CE; Maclean CC; McClellan MB; Owens DK
Ann Intern Med; 2003 May; 138(9):724-35. PubMed ID: 12729427
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Clinical and economic outcomes assessment in nuclear cardiology.
Shaw LJ; Miller DD; Berman DS; Hachamovitch R
Q J Nucl Med; 2000 Jun; 44(2):138-52. PubMed ID: 10967624
[TBL] [Abstract][Full Text] [Related]
5. Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy.
Gugiatti A; Grimaldi A; Rossetti C; Lucignani G; De Marchis D; Borgonovi E; Fazio F
Q J Nucl Med Mol Imaging; 2004 Mar; 48(1):49-61. PubMed ID: 15195004
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation studies in nuclear medicine: a methodological review of the literature.
Gambhir SS; Schwimmer J
Q J Nucl Med; 2000 Jun; 44(2):121-37. PubMed ID: 10967623
[TBL] [Abstract][Full Text] [Related]
7. [Quality criteria for cost-benefit analysis in oncologic nuclear medicine and state of its realization].
Dietlein M; Scheidhauer K; Lauterbach KW; Schicha H
Z Arztl Fortbild Qualitatssich; 1999 Jan; 93(1):49-55. PubMed ID: 10198979
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
Vriens D; Adang EM; Netea-Maier RT; Smit JW; de Wilt JH; Oyen WJ; de Geus-Oei LF
J Clin Endocrinol Metab; 2014 Sep; 99(9):3263-74. PubMed ID: 24873995
[TBL] [Abstract][Full Text] [Related]
9. [Cost-effectiveness of radiopharmaceuticals in the hospital].
Fotopoulos A
Hell J Nucl Med; 2005; 8(1):29. PubMed ID: 15886749
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease.
Garber AM; Solomon NA
Ann Intern Med; 1999 May; 130(9):719-28. PubMed ID: 10357690
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.
Dietlein M; Weber K; Gandjour A; Moka D; Theissen P; Lauterbach KW; Schicha H
Eur J Nucl Med; 2000 Oct; 27(10):1441-56. PubMed ID: 11083532
[TBL] [Abstract][Full Text] [Related]
12. Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography.
Klose T; Leidl R; Buchmann I; Brambs HJ; Reske SN
Eur J Nucl Med; 2000 Oct; 27(10):1457-64. PubMed ID: 11083533
[TBL] [Abstract][Full Text] [Related]
13. Virtual chromoendoscopy for the real-time assessment of colorectal polyps in vivo: a systematic review and economic evaluation.
Picot J; Rose M; Cooper K; Pickett K; Lord J; Harris P; Whyte S; Böhning D; Shepherd J
Health Technol Assess; 2017 Dec; 21(79):1-308. PubMed ID: 29271339
[TBL] [Abstract][Full Text] [Related]
14. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
15. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
16. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
Gambhir SS; Hoh CK; Phelps ME; Madar I; Maddahi J
J Nucl Med; 1996 Sep; 37(9):1428-36. PubMed ID: 8790186
[TBL] [Abstract][Full Text] [Related]
17. [Costing nuclear medicine diagnostic procedures].
Markou P
Hell J Nucl Med; 2005; 8(1):27-8. PubMed ID: 15886748
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck.
Hollenbeak CS; Lowe VJ; Stack BC
Cancer; 2001 Nov; 92(9):2341-8. PubMed ID: 11745289
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
